PMDA — authorised 23 December 2022
- Marketing authorisation holder: NIPPON SHIKA YAKUHIN CO., LTD.
- Status: approved
PMDA authorised Carbocaine on 23 December 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 December 2022.
NIPPON SHIKA YAKUHIN CO., LTD. holds the Japanese marketing authorisation.